Comparative outcomes of autologous great saphenous vein versus polytetrafluoroethylene arteriovenous grafts in hemodialysis patients with exhausted upper‑extremity vascular access

Background For hemodialysis patients with exhausted upper‑extremity vascular access, autologous great saphenous vein (GSV) serves as an important reconstructive alternative when upper‑arm native fistulas cannot be created. Real‑world comparative evidence between GSV and polytetrafluoroethylene (PTFE) grafts in this high‑risk subgroup remains scarce. This study compared graft patency and complications between GSV and PTFE conduits using propensity‑score‑matched cohort data. Methods This dual‑center retrospective study enrolled maintenance hemodialysis patients with exhausted upper‑extremity access. Patients were 1:1 propensity‑score matched into GSV (n = 30) and PTFE (n = 30) groups, balanced for key clinical covariates (SMD < 0.1). All participants completed 24‑month follow‑up. Primary endpoints were 24‑month primary and secondary graft patency; secondary outcomes included thrombosis, infection, stenosis and interventional events. Kaplan‑Meier and appropriate statistical tests were applied. The study was retrospectively registered (ChiCTR2500112130, 12 March 2025). Results Baseline features were well balanced after PSM. The GSV group achieved superior 24‑month primary patency (86.7% vs. 63.3%, P < 0.05), with numerically better secondary patency (90.0% vs. 76.7%). GSV exhibited lower rates of thrombosis and access‑site infection. Competing mortality was documented during follow‑up. Given limited primary‑patency failure events, multivariable prognostic modelling was not performed. Conclusions For hemodialysis patients with exhausted upper‑extremity vascular access, autologous GSV graft yields better 24‑month primary patency and favourable safety compared with PTFE prosthetic grafts. Larger multicenter investigations are needed to validate these observations.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-20
DOI
https://doi.org/10.21203/rs.3.rs-11142919/v1
Primary Topic
Central Venous Catheters and Hemodialysis
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Comparative outcomes of autologous great saphenous vein versus polytetrafluoroethylene arteriovenous grafts in hemodialysis patients with exhausted upper‑extremity vascular access

Fengmei Huang, Jianwen Wu, Xiaojie Xie, Lina Deng et al.
Research Square
Central Venous Catheters and Hemodialysis
preprint

Comparative outcomes of autologous great saphenous vein versus polytetrafluoroethylene arteriovenous grafts in hemodialysis patients with exhausted upper‑extremity vascular access

Fengmei Huang, Jianwen Wu, Xiaojie Xie, Lina Deng, Shifen Guan, Yan Li, Ran Zhang, Gaosi Xu
preprint en

Abstract

Background For hemodialysis patients with exhausted upper‑extremity vascular access, autologous great saphenous vein (GSV) serves as an important reconstructive alternative when upper‑arm native fistulas cannot be created. Real‑world comparative evidence between GSV and polytetrafluoroethylene (PTFE) grafts in this high‑risk subgroup remains scarce. This study compared graft patency and complications between GSV and PTFE conduits using propensity‑score‑matched cohort data. Methods This dual‑center retrospective study enrolled maintenance hemodialysis patients with exhausted upper‑extremity access. Patients were 1:1 propensity‑score matched into GSV (n = 30) and PTFE (n = 30) groups, balanced for key clinical covariates (SMD < 0.1). All participants completed 24‑month follow‑up. Primary endpoints were 24‑month primary and secondary graft patency; secondary outcomes included thrombosis, infection, stenosis and interventional events. Kaplan‑Meier and appropriate statistical tests were applied. The study was retrospectively registered (ChiCTR2500112130, 12 March 2025). Results Baseline features were well balanced after PSM. The GSV group achieved superior 24‑month primary patency (86.7% vs. 63.3%, P < 0.05), with numerically better secondary patency (90.0% vs. 76.7%). GSV exhibited lower rates of thrombosis and access‑site infection. Competing mortality was documented during follow‑up. Given limited primary‑patency failure events, multivariable prognostic modelling was not performed. Conclusions For hemodialysis patients with exhausted upper‑extremity vascular access, autologous GSV graft yields better 24‑month primary patency and favourable safety compared with PTFE prosthetic grafts. Larger multicenter investigations are needed to validate these observations.

Research Square
Nanchang University (CN), Second Affiliated Hospital of Nanchang University (CN)
Central Venous Catheters and Hemodialysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon